XM does not provide services to residents of the United States of America.

China stocks inch up, stimulus effectiveness in focus



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>China stocks inch up, stimulus effectiveness in focus</title></head><body>

Updates to midday

By Summer Zhen

HONG KONG, Oct 22 (Reuters) -China and Hong Kong stocks moved higher onTuesday as investors digested Beijing's latest stimulus measures, including fresh ratecuts the previous day.

Also boosting the market sentiment, the country's central bank kicked off its first operations on Monday under a swap facility designed to revive the stock market, exchanging assets worth 50 billion yuan ($7 billion) with brokerages, fund companies and insurers.

By midday, both theblue-chip CSI300 Index .CSI300 and theShanghai Composite Index .SSEC went up 0.5%.

Hong Kong benchmark Hang Seng .HSI rose 0.5%, whileChinese H-shares listed in Hong Kong, the Hang Seng China Enterprises Index .HSCE climbed 0.7%.

Stocks have wobbled in recent sessions after a roller coaster ride in the past few weeks following a raft of policy announcements out of Beijing.

Investors have turned cautious on whether the policy support will be sufficient to revive growth.

Still, the ongoing implementation of easing measures and the better-than-expected third quarter economic growth data put some floor under the stock market, market participants say.

"For now, we give policymakers the benefit of the doubt that China's business cycle will improve following the latest growth push and remain overweight on Chinese stocks," said Yan Wang, China Strategist of Alpine Macro.

Markets will soon look for evidence of whether the easing measures will bear fruit, he added.

By sector,media and auto stocks were outperformers, up 4.4% and 2.6%, respectively.

Additionally, Chinese corporates are converting more of their foreign exchange holdings into yuan and overseas investors have increased purchases of local stocks since September, the country's foreign exchange regulator said on Tuesday.

Around the region, MSCI's Asia ex-Japan stock index .MIAPJ0000PUS was weaker by 0.52% while Japan's Nikkei index .N225 was down 1.30%.

The yuan CNY=CFXS was quoted at 7.1244 per U.S. dollar, 0.05% weaker than the previous close of 7.121.


China stocks rally strongly https://reut.rs/3ZQNtV0

China's benchmark stock index logs biggest daily gain since 2008 https://reut.rs/4dmrDfq


Reporting by Summer Zhen; Editing by Sonali Paul and Christian Schmollinger

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.